Vir Biotechnology, Inc. VIR
- tobevibart — Chronic Hepatitis Delta Phase 3
- tobevibart — Chronic Hepatitis B Phase 2
HBsAg (1 companies · 2 programs)
Companies with an active program directed at HBsAg.
Companies with an active program directed at HBsAg.